ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,572.85
0.10%
US Tech 100
19,968.00
0.37%
Dow Jones
39,344.79
-0.08%
Brent Oil
85.135
-0.33%
Bitcoin
57,434.35
1.28%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Daxor Corporation (DXR) Quote

Daxor Corporation

Daxor Corporation (DXR)

Dynamic Active Retirement Income ETF
8.785
0.29
(3.35%)
Closed July 08 4:00PM
Delayed by 15 minutes
8.785
0.00
( 0.00% )
Pre Market: 4:16AM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
8.785
Bid
3.41
Ask
12.79
Volume
-
0.00 Day's Range 0.00
7.11 52 Week Range 10.1499
Market Cap
36.863M
Previous Close
8.785
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
1,514
Shares Outstanding
4,196,182
Dividend Yield
-
PE Ratio
131.04
Earnings Per Share (EPS)
0.07
Revenue
163k
Net Profit
281k

About Daxor Corporation

Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. It develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and compos... Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. It develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions. Show more

Sector
Surgical,med Instr,apparatus
Industry
Misc Health & Allied Svc,nec
Website
www.daxor.com
Headquarters
Oak Ridge, New Jersey, USA
Founded
2010
Daxor Corporation is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker DXR. The last closing price for Daxor was $8.79. Over the last year, Daxor shares have traded in a share price range of $ 7.11 to $ 10.1499.

Daxor currently has 4,196,182 shares outstanding. The market capitalization of Daxor is $36.86 million. Daxor has a price to earnings ratio (PE ratio) of 131.04.

DXR Latest News

More News

Daxor Corporation to Showcase the Benefits of BVA-100™ Guided-Care at the American Association of Heart Failure Nurses (AAHFN) 20th Annual Meeting

Oak Ridge, TN, June 18, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces today it will exhibit at the American...

June 18 2024
GlobeNewswire Inc.

Form 8-K - Current report

June 05 2024
Edgar (US Regulatory)

Daxor Corporation Appoints John L. Jefferies, M.D. as Chief Medical Officer

Oak Ridge, TN, June 05, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces the appointment of Dr. John L...

June 05 2024
GlobeNewswire Inc.

Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public)

May 30 2024
Edgar (US Regulatory)

New Studies Prove the Clinical Benefits of Daxor’s Blood Volume (BVA-100TM) Diagnostic In Ambulatory Heart Failure Patients For Measurement of Congestion

Data Presented at the American College of Cardiology Scientific Sessions; Research Letter Published in the Prestigious American Heart Journal Oak Ridge, TN, April 16, 2024 (GLOBE NEWSWIRE...

April 16 2024
GlobeNewswire Inc.

DAXOR CORPORATION TO EXHIBIT AT THE MEDAXIOM CARDIOVASCULAR TRANSFORUM CONFERENCE SPRING’24 TO ADVANCE AWARENESS AND FURTHER ADOPTION OF DAXOR’S BLOOD VOLUME DIAGNOSTIC (BVA-100™)

The Premier Event for Cardiovascular Industry Leaders and Clinicians Oak Ridge, TN, April 15, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume...

April 15 2024
GlobeNewswire Inc.

Daxor Corporation Announces New Hospital Account at Leading Chicago Hospital

450-Bed Hospital Purchases BVA-100™ Blood Volume Analyzer to Launch Heart Failure Program Oak Ridge, TN, April 10, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in...

April 10 2024
GlobeNewswire Inc.

Daxor Corporation to Exhibit at the American College of Cardiology for ACC.24

Oak Ridge, TN, April 01, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces it will be exhibiting at the American...

April 01 2024
GlobeNewswire Inc.

Daxor Corporation Acquires Volumex® and Megatope® From Its Existing Supplier Along With Glofil® to Enhance Existing Suite of Diagnostics

Expected to Improve Margins and Increase Revenue Streams Oak Ridge, TN, March 25, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement...

March 25 2024
GlobeNewswire Inc.

Daxor Corporation to Hold Investor Call Discussing Fiscal Year 2023 Financial Results and Corporate Update on March 25, 2024

Oak Ridge, TN, March 22, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces an investor call to be held on Monday...

March 22 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.0150.1710376282788.778.968.56798.741417CS
40.2352.74853801178.559.60018.58159.00128236CS
12-0.745-7.817418677869.539.99998.215149.52953541CS
26-1.025-10.44852191649.8110.037.1920978.99123922CS
52-0.955-9.804928131429.7410.14997.1124939.12572818CS
156-2.185-19.917958067510.9714.557.11388710.19849581CS
260-2.185-19.917958067510.9714.557.11388710.19849581CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
WENAANEW MEDICAL INC
$ 2.88
(98.62%)
3.94M
PEGYPineapple Energy Inc
$ 2.07
(72.50%)
7.22M
ZAPPZapp Electric Vehicles Group Ltd
$ 12.58
(36.15%)
1.48M
SVMHSRIVARU Holding Ltd
$ 0.2247
(18.26%)
1.91M
BTCSBTCS Inc
$ 1.63
(16.43%)
160
INDVIndivior PLC
$ 9.50
(-38.07%)
76.6k
SHPWShapeways Holdings Inc
$ 0.376
(-22.89%)
221.29k
TXMDTherapeuticsMD Inc
$ 1.38
(-18.84%)
24
GNLNGreenlane Holdings Inc
$ 0.2375
(-17.88%)
1.45M
TNXPTonix Pharmaceuticals Holding Corporation
$ 0.5955
(-16.41%)
82.36k
MAXNMaxeon Solar Technologies Ltd
$ 0.2726
(0.96%)
7.87M
PEGYPineapple Energy Inc
$ 2.07
(72.50%)
7.22M
MYNZMainz BioMed NV
$ 0.535
(12.16%)
5.58M
WENAANEW MEDICAL INC
$ 2.88
(98.62%)
3.94M
SVMHSRIVARU Holding Ltd
$ 0.2247
(18.26%)
1.91M

Discussion

View Full Feed
PJ3000 PJ3000 2 minutes ago
Anyone besides me wondering where all this trading volume is coming from all of a sudden? There used to be thousands of shares changing hands, now it's a few 100k. While a few 100m currently restricted ones wait to join the party
OLVI
TRUSTUNITS1000000 TRUSTUNITS1000000 3 minutes ago
Wonder about the grant
AMHD
TechandBio TechandBio 4 minutes ago
Re examining the chart mid 20.00's in play for Zapp
ICCM IceCure is another one that could run 1500% to 10.00 Killing cancer with cryoblast is disruptive 96% non recurrence after 5 year follow up with patients for breast cancer is disruptive. Also treats lung Kidney and bone cancers imagine
ICCM ZAPP
ziploc_1 ziploc_1 4 minutes ago
There is some confusion as to what the rights Amarin and Mochida each have to market the products of their collaboration agreement of 2018.


QUOTE..."Among other terms in the agreement, Amarin obtained an EXCLUSIVE license to certain Mochida intellectual property to advance Am
AMRN
TRUSTUNITS1000000 TRUSTUNITS1000000 4 minutes ago
Someone said the business still exists
INDR
TRUSTUNITS1000000 TRUSTUNITS1000000 5 minutes ago
Shareholders post
INDR
TRUSTUNITS1000000 TRUSTUNITS1000000 6 minutes ago
0.0001
AABB
Diamondhands45 Diamondhands45 6 minutes ago
Link to article?
TSLA
TRUSTUNITS1000000 TRUSTUNITS1000000 6 minutes ago
Keeps dropping
AABB
TRUSTUNITS1000000 TRUSTUNITS1000000 8 minutes ago
Terrible
TRUSTUNITS1000000 TRUSTUNITS1000000 9 minutes ago
Cb has other ventures I think
ICNB
TRUSTUNITS1000000 TRUSTUNITS1000000 9 minutes ago
Interesting drink
ICNB
TRUSTUNITS1000000 TRUSTUNITS1000000 10 minutes ago
So much for cb 50%
ICNB
TRUSTUNITS1000000 TRUSTUNITS1000000 10 minutes ago
Stock price 0.0000000
ICNB
TRUSTUNITS1000000 TRUSTUNITS1000000 12 minutes ago
Look at EEENF
EEENF
TRUSTUNITS1000000 TRUSTUNITS1000000 13 minutes ago
Management make us happy
TGGI
Large Green Large Green 14 minutes ago
Newflow, access denied, Were you able to get access?

...
COOP
TRUSTUNITS1000000 TRUSTUNITS1000000 14 minutes ago
0.0001
MJNA
TRUSTUNITS1000000 TRUSTUNITS1000000 15 minutes ago
Neat 🚘 a while back
SGMD
TRUSTUNITS1000000 TRUSTUNITS1000000 15 minutes ago
Funny volume
SGMD
TRUSTUNITS1000000 TRUSTUNITS1000000 16 minutes ago
Interesting company
SGMD
TRUSTUNITS1000000 TRUSTUNITS1000000 17 minutes ago
Do you think 🤔 the financials were fake, cash balance $000,000 ???????
VGID
TRUSTUNITS1000000 TRUSTUNITS1000000 18 minutes ago
Interesting 🤔 it still trades
ONCI
JV44 JV44 18 minutes ago
Maybe a QX one day....one step at a time ...GLTUA...Go Megola Team and Go Breakthrough Chemistry Team! 🫡🌲🌲🌲🌲🌲💰️
MGON
vegasopc vegasopc 19 minutes ago
Daily monster runner. Love this one! $$$
ANVS

Your Recent History

NASDAQ
DXR
Daxor
BIT
MTS
MiT Sim
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved